Procaps Group SA develops and markets OTC pharmaceuticals and supplements, focusing on global healthcare accessibility.

Procaps Group SA (NASDAQ:PROC) operates in the pharmaceutical and health sector, focusing on developing, manufacturing, and marketing over-the-counter (OTC) pharmaceuticals and prescription drugs, along with advanced clinical nutrition products and supplements. Leveraging state-of-the-art technology, the company embraces a robust research and development approach to create innovative health solutions. With a global footprint, Procaps prioritizes expanding its reach in international markets through strategic partnerships, aiming to enhance access to affordable and high-quality healthcare products. The company is dedicated to sustainability and improving patient outcomes, aligning its projects and objectives with the broader goal of transforming the way healthcare is delivered around the world.
GET YOUR GRAFA EDGE NOW
Sign up free to follow this company
We'll switch on a 30-day Edge trial as a welcome gift